factors to consider regarding frailty assessment in elderly patients with myeloma
Published 1 year ago • 57 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
4:08
factors to consider when approaching r/r multiple myeloma
-
5:39
identifying vulnerable patients with multiple myeloma
-
2:31
the future of multiple myeloma treatment: genetic tests and frailty
-
3:05
recent advances in newly diagnosed multiple myeloma and the importance of patient perspectives
-
3:38
outcomes for patients with multiple myeloma who have had first-line monoclonal antibody exposure
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
1:00:48
faqs on multiple myeloma precursor conditions
-
4:57
versiti blood research institute | expanding the frontiers of patient health
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
0:43
the importance of improving precision when risk stratifying patients with multiple myeloma
-
4:51
risk stratification & treatment of multiple myeloma precursor conditions
-
2:23
factors to consider when selecting jak inhibitors for patients with mf
-
1:47
the role of precursor conditions in myeloma
-
2:31
defining precursor conditions in multiple myeloma & strategies to better predict risk of progression
-
1:40
utilizing ai for individualized treatment-adjusted risk stratification in newly diagnosed myeloma
-
2:37
meta-analysis of studies on biomarker-defined early multiple myeloma
-
0:53
the future of next-generation sequencing assays in myeloma treatment
-
0:39
factors to consider when selecting patients with scd for allosct
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:38
therapeutically targeting transcription factors in cll
-
1:22
an all-molecular diagnostic approach for myeloma